MEI Pharma, Inc. Quarterly Debt-to-equity in % from Q1 2019 to Q1 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
MEI Pharma, Inc. quarterly Debt-to-equity history and growth rate from Q1 2019 to Q1 2024.
  • MEI Pharma, Inc. Debt-to-equity for the quarter ending March 31, 2024 was 71.8 %, a 72.5% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q1 2024 71.8 -190 -72.5% Mar 31, 2024
Q4 2023 118 -114 -49.3% Dec 31, 2023
Q3 2023 167 -55.9 -25.1% Sep 30, 2023
Q2 2023 291 +58.7 +25.2% Jun 30, 2023
Q1 2023 261 +26 +11% Mar 31, 2023
Q4 2022 232 -23.7 -9.26% Dec 31, 2022
Q3 2022 223 -21.7 -8.86% Sep 30, 2022
Q2 2022 233 +38.1 +19.6% Jun 30, 2022
Q1 2022 235 +56.2 +31.4% Mar 31, 2022
Q4 2021 256 +125 +95.7% Dec 31, 2021
Q3 2021 244 +144 +143% Sep 30, 2021
Q2 2021 195 +120 +161% Jun 30, 2021
Q1 2021 179 +135 +309% Mar 31, 2021
Q4 2020 131 +66.8 +105% Dec 31, 2020
Q3 2020 101 +21.7 +27.4% Sep 30, 2020
Q2 2020 74.7 -26.2 -26% Jun 30, 2020
Q1 2020 43.9 -66.3 -60.2% Mar 31, 2020
Q4 2019 63.8 Dec 31, 2019
Q3 2019 78.9 Sep 30, 2019
Q2 2019 101 Jun 30, 2019
Q1 2019 110 Mar 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.